Cholangiocarcinome

Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.

Leave a Comment / Cholangiocarcinome / By

Alitti C, Rode A, Trillaud H, Merle P, Blanc JF, Blaise L, Demory A, Nkontchou G, Grando V, Ziol M, Nahon P, Ganne-Carrié N, Petit A, Seror O, Sutter O, Nault JC.Liver Int. 2024 Jun;44(6):1363-1372. doi: 10.1111/liv.15886. Epub 2024 Mar 4.PMID: 38436538 Abstract Introduction: The effectiveness of percutaneous radiofrequency ablation (RFA) in intrahepatic cholangiocarcinomas (iCCA) remains insufficiently studied. …

Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma. Read More »

Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma

CHC, Cholangiocarcinome / By

Calderaro J, Di Tommaso L, Maillé P, Beaufrère A, Nguyen CT, Heij L, Gnemmi V, Graham RP, Charlotte F, Chartier S, Wendum D, Vij M, Allende D, Diaz A, Fuster C, Rivière B, Herrero A, Augustin J, Evert K, Calvisi DF, Leow WQ, Wai Leung HH, Bednarsch J, Boleslawski E, Rela M, Wing-Hung Chan A, …

Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma Read More »

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma

CHC, Cholangiocarcinome / By

Gigante E, Hobeika C, Le Bail B, Paradis V, Tougeron D, Lequoy M, Bouattour M, Blanc JF, Ganne-Carrié N, Tran H, Hollande C, Allaire M, Amaddeo G, Regnault H, Vigneron P, Ronot M, Elkrief L, Verset G, Trepo E, Zaanan A, Ziol M, Ningarhari M, Calderaro J, Edeline J, Nault JC Abstract Backgrounds and aims: Even if …

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma Read More »

Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice

CHC, Cholangiocarcinome / By

Desjonqueres E, Campani C, Marra F, Zucman-Rossi J, Nault JC.Liver Int. 2022 Jan 4. doi: 10.1111/liv.15152.  Abstract Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the most frequent primary liver cancers, accounting for approximately 80% and 15%, respectively. HCC carcinogenesis occurs mostly in cirrhosis and is a complex multi-step process, from precancerous lesions (low-grade and high-grade dysplastic …

Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice Read More »

Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy

Cholangiocarcinome / By

Nguyen CT, Caruso S, Maillé P, Beaufrère A, Augustin J, Favre L, Pujals A, Boulagnon-Rombi C, Rhaiem R, Amaddeo G, Di Tommaso L, Luciani A, Regnault H, Brustia R, Scatton O, Charlotte F, Brocheriou I, Sommacale D, Soussan P, Leroy V, Laurent A, Le VK, Ta VT, Trinh HS, Tran TL, Gentien D, Rapinat A, Nault …

Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy Read More »